Lido Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-100
Closed -$88.6K 1554
2024
Q3
$88.6K Hold
100
﹤0.01% 1404
2024
Q2
$90.5K Hold
100
﹤0.01% 1348
2024
Q1
$77.8K Hold
100
﹤0.01% 1331
2023
Q4
$58.3K Buy
+100
New +$58.4K ﹤0.01% 1310

Other funds holding LLY

Lido Advisors's LLY Position: Q1 2026 in Review

Lido Advisors reduced its Eli Lilly (LLY) stake by 17% in Q1 2026, selling an estimated $22.1M and leaving 108,867 shares worth $100M. The position accounts for 0.31% of the portfolio, ranked #53.

Lido Advisors first reported a position in LLY in Q1 2016 and has held it in 34 quarters since. The position peaked at $113M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Lido Advisors held 108,867 shares of Eli Lilly worth $100M as of Q1 2026.
  • Lido Advisors sold 21,808 Eli Lilly shares in Q1 2026, an estimated $22.1M.
  • Eli Lilly made up 0.31% of Lido Advisors's portfolio in Q1 2026, its #53 holding.
  • Lido Advisors first reported a position in Eli Lilly in Q1 2016 and has held it in 34 quarters since.
  • Lido Advisors's Eli Lilly position peaked at $113M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.